CP-100 Pegylated interferon ALFA 2-A in myeloproliferative neoplasms

• Published in: European journal of hospital pharmacy. Science and practice Vol. 24; no. Suppl 1; p. A44
• Main Authors: Scaldaferri, M, Varese, A, Tonelli, M, Barilà, D, Bianco, A, Valinotti, G, Caiazza, E, Martinetto, D, Ferroni, M, Cattel, F
• Format: Journal Article
• Language: English
• Published: London BMJ Publishing Group LTD 01.03.2017
• Subjects: Blood cancer; Interferon; Mutation; Phlebotomy; Tumors

BackgroundPolycythaemia vera (PV), essential thrombocythemia (TE) and myelofibrosis (MF) are myeloproliferative neoplasms (MPN), characterised by a number of mutations related to proliferation and differentiation of myeloid cell lines. Peg-interferon α2a (P-IFN) is considered a promising option for...